Prognosis of Alzheimer's disease today: A two-year prospective study in 686 patients from the REAL-FR Study

Alzheimer's and Dementia

Volumn 4, Issue 1, 2008, Pages 22-29

  Cortes, Frédéric ^a,b   Nourhashémi, Fati ^a,b   Guérin, Olivier ^c   Cantet, Christelle ^a,b   Gillette Guyonnet, Sophie ^a,b   Andrieu, Sandrine ^b,d   Ousset, Pierre Jean ^a   Vellas, Bruno ^a,b  

^a CHU PURPAN   (France)

^b INSERM   (France)

^c UNIVERSITY HOSPITAL OF NICE   (France)

^d Department of Epidemiology and Public Health ^*  (France)

Author keywords

Alzheimer's disease; Evolution; Prospective study; Specific management; Specific treatments

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR CHANGE; COGNITION; COHORT ANALYSIS; CONFIDENCE INTERVAL; DAILY LIFE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; FRANCE; FUNCTIONAL STATUS; HOSPITALIZATION; HUMAN; INCIDENCE; INSTITUTIONALIZATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MENTAL DETERIORATION; MINI MENTAL STATE EXAMINATION; MORTALITY; NEUROPSYCHIATRY; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PSYCHOLOGICAL RATING SCALE; TREATMENT RESPONSE;

ACTIVITIES OF DAILY LIVING; AGED; ALZHEIMER DISEASE; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; NUTRITION ASSESSMENT; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES;

EID: 38049095597     PISSN: 15525260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jalz.2007.10.018     Document Type: Article

References (23)

1. Courtney C., Farrell D., Gray R., Hills R., Lynch L., Sellwood E., et al. AD 2000 Collaborative Group. long term donepezil treatment in 565 patients with Alzheimer's disease (AD 2000)-randomised double blind trial. Lancet 363 (2004) 2105-2115
2. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (1994), APA, Washington, DC
4. Gillette-Guyonnet S., Nourhashemi F., Andrieu S., Cantet C., Micas M., Ousset P.J., et al. REAL.FR group: the REAL.FR research program on Alzheimer's disease and its management: methods and preliminary results. J Nutr Health Aging 7 (2003) 91-96
5. Folstein M.F., Folstein S.E., and McHugh P.R. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975) 189-198
6. Rosen W.G., Mohs R.C., and Davis K.L. A new rating scale for Alzheimer's disease. Am J Psychiatry 141 (1984) 1356-1364
7. Katz S., Ford A.B., Moskowitz R.W., Jackson B.A., and Jaffe M.W. The index of ADL: A standardized measure of biological and psychosocial function. JAMA 185 (1963) 914-919
8. Cummings J.L., Mega M., Gray K., Rosenberg-Thompson S., Carusi D.A., and Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44 (1994) 2308-2314
9. Vellas B., Guigoz Y., Garry P.J., Nourhashemi F., Bennahum D., Lauque S., et al. The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition 2 (1999) 116-122
10. Hughes C.P., Berg L., Danziger W.L., Coben L.A., and Martin R.L. A new clinical scale for the staging of dementia. Br J Psychiatry 140 (1982) 566-572
11. Mohs R.C., Schmeidler J., and Aryan M. Longitudinal studies of cognitive, functional and behavioural changes in patients with Alzheimer's disease. Stat Med 19 (2000) 1401-1409
12. Miliken J.K., and Edland S.D. Mixed effect models of longitudinal Alzheimer's data: a cautionary note. Stat Med 19 (2000) 1617-1629
13. Cortes F., Gillette-Guyonnet S., Nourhashemi F., Andrieu S., Cantet C., and Vellas B. Recent data on the natural history of Alzheimer's disease: results from the REAL.FR Study. J Nutr Health Aging 9 (2005) 86-93
14. Dumont C., Voisin T., Nourhashemi F., Andrieu S., Koning M., and Vellas B. Predictive factors for rapid loss on the mini-mental state examination in Alzheimer's disease. J Nutr Health Aging 9 (2005) 163-167
15. Morris J.C., Edland S., Clark C., Galasko D., Koss E., Mohs R., et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): part IV-rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology 43 (1993) 2457-2465
16. Stern R.G., Mohs R.C., Davidson M., Schmeidler J., Silverman J., Kramer-Ginsberg E., et al. A longitudinal study of Alzheimer's disease: measurement, rate and predictors of cognitive deterioration. Am J Psychiatry 151 (1994) 390-396
17. Green C.R., Mohs R.C., Schmeidler J., Aryan M., and Davis K.L. Functional decline in Alzheimer's disease: a longitudinal study. J Am Geriatr Soc 41 (1993) 654-661
18. Mega M.S., Masterman D.M., O'Connor S.M., Barclay T.R., and Cummings J.L. The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer's disease. Arch Neurol 56 (1999) 1388-1393
19. Mega M.S., Cummings J.L., Fiorello T., and Gornbein J. The spectrum of behavioral changes in Alzheimer's disease. Neurology 46 (1996) 130-135
20. Landes A.M., Sperry S.D., Strauss M.E., and Geldmacher D.S. Apathy in Alzheimer's disease. J Am Geriatr Soc 49 (2001) 1700-1707
21. Vellas B., Lauque S., Gillette-Guyonnet S., Andrieu S., Cortes F., Nourhashemi F., et al. Impact of nutritional status on the evolution of Alzheimer's disease and on response to acetylcholinesterase inhibitor treatment. J Nutr Health Aging 9 (2005) 75-80
22. Gillette-Guyonnet S., Andrieu S., Cortes F., Nourhashemi F., Cantet C., Ousset P.J., et al. Outcome of Alzheimer's disease: potential impact of cholinesterase inhibitors. J Gerontol A Biol Sci Med Sci 61 (2006) 516-520
23. Massoud F., Devi G., Stern Y., Lawton A., Goldman J.E., Liu Y., et al. A clinicopathological comparison of community-based and clinic-based cohorts of patients with dementia. Arch Neurol 56 (1999) 1368-1373